Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Loss of Y Chromosome in Aortic Stenosis

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The most common heart valve disease in humans is aortic stenosis which is a critical narrowing of the valve through which the heart has to pump blood to the rest of the body. This condition occurs in 2-3% of adults over 65 years of age and when it progresses to a severe stage leads to heart failure and need for valve replacement procedures (including surgery and catheter-based replacement). Aortic stenosis has a strong male predominance. The purpose of this study is to evaluate whether loss of Y-chromosome from circulating blood cells in males, which has been associated with TGF-beta-related fibrosis of other organs, is associated with the development of aortic stenosis.

Who May Be Eligible (Plain English)

Who May Qualify: - Aortic stenosis (valve area \<1.5cm2) Who Should NOT Join This Trial: - Bicuspid aortic valve - History of radiation to chest - Inflammatory (autoimmune, rheumatologic) disease associated with aortic stenosis - Active cancer Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Aortic stenosis (valve area \<1.5cm2) Exclusion Criteria: * Bicuspid aortic valve * History of radiation to chest * Inflammatory (autoimmune, rheumatologic) disease associated with aortic stenosis * Active cancer

Treatments Being Tested

DIAGNOSTIC_TEST

Blood analysis for loss-of-Y chromosome

Analysis for the percentage of circulating leukocytes with loss-of-y chromosome

Locations (1)

University of Virginia
Charlottesville, Virginia, United States